A recent study demonstrates that HBx stabilizes PAX8 by inhibiting the Skp2-dependent ubiquitination in hepatoma cells, thereby contributing to the cell clonogenicity and proliferation and its growth in vivo, which might promotes the progression of HBV-related HCC (88). Here, PAX8 is linked to hepatocellular carcinoma.